This inventor holds 1 USPTO granted patent. Top assignee: Aragon Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Matthieu Garin: Innovator in Anticancer Compositions
Introduction
Matthieu Garin is a notable inventor based in Wemmel, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer compositions. His work focuses on innovative solutions for treating androgen receptor-related diseases, including prostate cancer.
Latest Patents
Garin holds a patent for pharmaceutical formulations of apalutamide. This invention is designed for administration to mammals, especially humans, suffering from conditions related to androgen receptors. The patent specifically addresses the treatment of prostate cancer, showcasing Garin's commitment to advancing cancer therapies. He has 1 patent to his name.
Career Highlights
Matthieu Garin is currently associated with Aragon Pharmaceuticals, Inc., where he continues to work on groundbreaking research in the pharmaceutical sector. His expertise in anticancer formulations has positioned him as a valuable asset in the fight against cancer.
Collaborations
Garin collaborates with talented professionals in his field, including Florentina Maria Preda and Reshema Kemps-Polanco. These partnerships enhance the research and development efforts at Aragon Pharmaceuticals, fostering innovation in cancer treatment.
Conclusion
Matthieu Garin's contributions to anticancer compositions reflect his dedication to improving patient outcomes in oncology. His innovative work continues to inspire advancements in pharmaceutical formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile